Literature DB >> 6124728

In vitro mefloquine resistant Plasmodium falciparum from the Philippines.

L L Smrkovski, R L Buck, A K Alcantara, C S Rodriguez, C V Uylance.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6124728     DOI: 10.1016/s0140-6736(82)90285-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Antimalarial agents: specific treatment regimens.

Authors:  D J Krogstad; B L Herwaldt; P H Schlesinger
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

2.  Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.

Authors:  T Harinasuta; D Bunnag; S Vanijanond; P Charoenlarp; P Suntharasmai; S Chitamas; U K Sheth; W H Wernsdorfer
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

Review 3.  Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  K J Palmer; S M Holliday; R N Brogden
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

Review 4.  Halofantrine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic potential.

Authors:  H M Bryson; K L Goa
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

5.  Falciparum malaria treated with a fixed combination of mefloquine, sulfadoxine and pyrimethamine: a field study in adults in Burma.

Authors:  F Tin; N Hlaing; T Tun; S Win; R Lasserre
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

Review 6.  Malaria prophylaxis in travellers: the current position.

Authors:  D Stürchler
Journal:  Experientia       Date:  1984-12-15

7.  In-vitro tests on Philippine isolates of Plasmodium falciparum against four standard antimalarials and four qinghaosu derivatives.

Authors:  M D Bustos; F Gay; B Diquet
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.